CRISPR Therapeutics to Present at Upcoming Investor Conferences
October 01 2019 - 07:00AM
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company
focused on creating transformative gene-based medicines for serious
diseases, today announced that members of its senior management
team are scheduled to make the following presentations in October:
Chardan’s 3rd Annual Genetic Medicines
Conference Date: Tuesday, October 8,
2019Presentation: 10:30 a.m. ET Location: New York, NY
Jefferies Gene Therapy/Editing Summit
Date: Tuesday, October 8, 2019 Panel Discussion: 1:10
p.m. ET Location: New York, NY
A live webcast of the events will be available on the "Events
& Presentations" page in the Investors section of the Company's
website at https://crisprtx.com/events. A replay of the
webcast will be archived on the Company's website for 14 days
following the presentation.
About CRISPR Therapeutics
CRISPR Therapeutics is a leading gene editing
company focused on developing transformative gene-based medicines
for serious diseases using its proprietary CRISPR/Cas9 platform.
CRISPR/Cas9 is a revolutionary gene editing technology that allows
for precise, directed changes to genomic DNA. CRISPR Therapeutics
has established a portfolio of therapeutic programs across a broad
range of disease areas including hemoglobinopathies, oncology,
regenerative medicine and rare diseases. To accelerate and expand
its efforts, CRISPR Therapeutics has established strategic
collaborations with leading companies including Bayer AG, Vertex
Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is
headquartered in Zug, Switzerland, with its wholly-owned U.S.
subsidiary, CRISPR Therapeutics, Inc., and R&D operations based
in Cambridge, Massachusetts, and business offices in London, United
Kingdom. For more information, please visit www.crisprtx.com.
Investor Contact:Susan
Kimsusan.kim@crisprtx.com
Media Contact:Jennifer PaganelliWCG on behalf
of CRISPR347-658-8290jpaganelli@wcgworld.com
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Feb 2024 to Mar 2024
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Mar 2023 to Mar 2024